What they were paid
Protara Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $65,000 | $0 | $54,991 | $0 | $119,991 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protara Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001213900-26-048536, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Protara Therapeutics pays directors a $40,000 cash retainer.
The rest of the Protara Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Barry Flannelly, Pharm.D | Independent Director | $100,991 |
| Cynthia Smith | Independent Director | $106,991 |
| Gregory Sargen | Independent Director | $109,991 |
| Jesse Shefferman | Director | $0 |
| Luke Beshar | Chair of the Board | $226,491 |
| Michael Solomon, Ph.D | Independent Director | $107,491 |
| Richard Levy, M.D | Independent Director | $149,491 |
| Roger Garceau, M.D | Independent Director | $121,491 |
The full Protara Therapeutics compensation record
free company briefThis page is one director within Protara Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat